Lexaria Bioscience Corp LEXX

Alternate Symbol(s): LEXXW

Healthcare

Lexaria Bioscience Corp. is a Canada-based biotechnology company. The Company is engaged in pursuing the enhancement of the bioavailability of a diverse and a range of active pharmaceutical ingredients (API) using DehydraTECH, its patented proprietary drug delivery technology. The Company’s patented drug delivery technology, DehydraTECH, is designed to improve the way active molecules enter the bloodstream upon oral ingestion. DehydraTECH has also demonstrated enhanced delivery of certain active molecules into brain tissue. The Company has also developed DehydraTECH formulations for other applications demonstrating bio-absorption when administered intraorally and topically. It operates through two segments: Intellectual Property and Products. It also operates a licensed in-house research laboratory and holds an intellectual property portfolio with 35 patents granted and many patents pending worldwide. Its subsidiaries include Lexaria CanPharm ULC, and Lexaria CanPharm Holdings Corp.

NDAQ:LEXX - Post by User

Lexaria Bioscience Corp > $BUYout soon IMHO

<< Previous

Bullboard Posts

Next >>

Comment by WakeUPPon Sep 15, 2021 1:54pm

124 Views

Post# 33862720

RE:$BUYout soon IMHO

OH, YOU predicte dit would be $20 by monday, 2 or more motnhs ago, then you predicted it would soon be $15, and now you are predicting $25????????

sadly, it is $6, and heading LOWER

a deal with a $14m penny stock promo, and postivie results from 10 rats is what you have

<< Previous

Bullboard Posts

Next >>

5 steps to mastering risk management in the stock market